Biogen prices new ALS drug at more than $14K per dose
Biogen has priced its new ALS drug Qalsody at $14,230 per dose, a spokesperson confirmed to Endpoints News on Monday.
Qalsody, also known as tofersen …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
